Consolidation Versus Independence in Cancer Care from AVBCC Value-Based Voices

Consolidation Versus Independence in Cancer Care

25 minutes Posted Feb 24, 2026 at 5:00 pm.

Introduction to the episode and guest

Clarifying consolidation and independence in oncology

Distinguishing One Oncology from roll-ups and private equity

The role of capital in practice growth and diversification

Market share, consolidation, and community options

Transitioning practices from hospital to community settings

Policy pressures and the need for scale in healthcare

The importance of leveling the playing field in healthcare

Future of value-based care in oncology

Early adoption of cell and gene therapies in the community

Community engagement in clinical trials and therapy adoption

The importance of data and analytics in oncology

Challenges in seamless data sharing and diagnostics

The impact of incentives and misaligned policies

Closing remarks and future outlook

0:00

25:10

Download MP3

Share at current time

Show notes

Is consolidation in cancer care truly the best path forward, or does independence offer greater benefits? In this episode of Value-Based Voices Sarah Alwardt, PhD, President, Avalere Health, and Jeff Patton, MD, CEO, OneOncology, discuss the nuances of consolidation versus independence in cancer care, the impact of policy and capital access, and the future of value-based oncology. Gain insights into sustainable models, data utilization, and patient-centered strategies. Contact Value-Based Vo...

← See all 6 episodes of AVBCC Value-Based Voices